coenzyme Q10/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on maximal oxygen uptake
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Cardiorespiratory fitness (CRF) and VO2 peak were not significantly different with NR and CoQ10 supplementation, with means of 21.38 ± 4.93 mL/min/kg (P = 0.36) and 21.41 ± 4.74 (P = 0.33), respectively and Table 2).”
Quoted verbatim from Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease.. - Study
- RCT
- Duration
- 6 weeks
- Dose
- 1200 mg/day
- Population
- adults with chronic kidney disease, eGFR under 60 mL/min/1.73m2
Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease.2023PMID:37159264Permalink
Keep reading
- Everything the graph holds on coenzyme Q10
- Every compound studied against Maximal oxygen uptake
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M1CV12YXWCPMV6ZW2CSEKDMM